Updated

Hedge fund BCSM disclosed that it exited its position in Heartflow, citing competitive concerns within the medical technology company's market, while maintaining a watchlist designation. Separately, the fund also exited its stake in Insulet Corporation. The moves reflect portfolio repositioning by the fund amid shifting competitive dynamics in the medical device sector.